Active Control, Double-blind, Double-dummy, Parallel-group, Randomized Study to Assess the Effect of VECAM 40/300, Administered at Bedtime, vs. Esomeprazole 20 mg, Administered 30-60 Min. Before Dinner, on Daytime and Nighttime GERD Symptoms
Clinical trial NCT01059383 · COMPLETED
Trial details
- NCT number
- NCT01059383
- Sponsor
- Vecta Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-06-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.